Showing results (1341-1350 of 1,373) with videos related to
Sort By:
Pageof 138
Physical Review Letters|March 21, 2015
Enhanced relativistic-electron-beam energy loss in warm dense aluminumX Vaisseau, A Debayle, J J Honrubia, et al.JAMA Oncology|August 12, 2018
Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysisFrancesca Gay, Graham Jackson, Laura Rosiñol, et al.Nature Medicine|February 5, 2025
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trialSaad Z Usmani, Thierry Facon, Vania Hungria, et al.Blood|March 24, 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease ResultsJill Corre, Laure Vincent, Philippe Moreau, et al.Clinical Hematology International|June 1, 2026
Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in FranceDecaux Olivier, Ronan Garlantezec, Aurore Perrot, et al.Blood Advances|May 5, 2026
Infections in Patients Receiving Daratumumab for Newly Diagnosed Multiple Myeloma: A Pooled Analysis of MAIA and ALCYONENizar J Bahlis, Thierry Facon, Jesús F San-Miguel, et al.Blood|January 9, 2007
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyélomeHervé Avet-Loiseau, Michel Attal, Philippe Moreau, et al.Blood|September 22, 2005
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapyThierry Facon, Jean-Yves Mary, Brigitte Pégourie, et al.Blood|January 11, 2015
Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial resultsXavier Leleu, Lionel Karlin, Margaret Macro, et al.Science (New York, N.Y.)|January 18, 2006
Interferometric coupling of the Keck telescopes with single-mode fibersG Perrin, J Woillez, O Lai, et al.Pageof 138